Collegium Pharmaceutical (COLL) reported $145.28 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 7.2%. EPS of $1.62 for the same period compares to $1.26 ...
Source LinkCollegium Pharmaceutical (COLL) reported $145.28 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 7.2%. EPS of $1.62 for the same period compares to $1.26 ...
Source Link
Comments